Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Cohen & Steers Shares Plunge to Annual Low Amid Executive Shake-Up

Robert Sasse by Robert Sasse
September 18, 2025
in Analysis, Earnings, Market Commentary
0
Cohen, Steers Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Shares of investment management firm Cohen & Steers tumbled to a fresh 52-week low of $68.31 during Tuesday’s trading session. The decline coincided with the company’s unexpected announcement that Chief Financial Officer Raja Dakkuri will be stepping down from his role, effective October 17.

This downward movement represents the security’s weakest valuation point in a year and extends a concerning pattern of depreciation. The stock has declined by a substantial 27.84% over the preceding twelve-month period. It concluded the previous trading day at $69.38, underscoring a persistent bearish sentiment.

Leadership Transition Adds to Market Uncertainty

The sudden departure of CFO Raja Dakkuri introduces a significant leadership challenge during an already volatile period for the company. Michael Donohue, who currently holds the position of Senior Vice President and Controller, is slated to assume the responsibilities of financial leadership on an interim basis starting in October. Cohen & Steers has initiated a search process to find a permanent successor, evaluating both internal and external candidates.

Donohue brings relevant experience from his previous role at Hamilton Lane, where he was a key figure in managing the firm’s initial public offering in 2017. Market observers are now questioning whether his appointment can help reverse the company’s current trajectory.

Second-Quarter Earnings Fail to Impress

Investor confidence was previously shaken by the company’s Q2 earnings report, released in July. The results presented a mixed picture; while revenue reached $135.32 million, surpassing market forecasts, earnings per share (EPS) of $0.73 fell short of the $0.75 consensus estimate.

Should investors sell immediately? Or is it worth buying Cohen, Steers?

This disappointing bottom-line performance has continued to fuel skepticism among the investment community regarding the firm’s near-term profitability.

Analyst Sentiment Remains Cautious

The prevailing analyst consensus for Cohen & Steers continues to be a “Hold” recommendation. However, several institutions have recently adopted a more pessimistic stance:
– Bank of America reduced its price target to $66 in July
– Evercore ISI adjusted its target down to $77 in early September
– The average price target across covering analysts currently stands at $81.67

From a technical analysis perspective, the stock is trading well below its key moving averages—$74.21 (50-day) and $76.43 (200-day)—a configuration typically interpreted as a bearish indicator.

Third-Quarter Report to Serve as Critical Catalyst

All eyes are now on the upcoming Q3 earnings release, scheduled for October 15, which will serve as a crucial test for the struggling equity. The concurrent search for a permanent CFO is likely to contribute additional layers of uncertainty. With a market capitalization of approximately $3.53 billion, investors are navigating a highly turbulent period for the asset manager.

The company’s specialized focus on real assets and alternative investment strategies inherently increases its sensitivity to interest rate fluctuations and broader market volatility. The current downward trend appears firmly established.

Ad

Cohen, Steers Stock: Buy or Sell?! New Cohen, Steers Analysis from February 7 delivers the answer:

The latest Cohen, Steers figures speak for themselves: Urgent action needed for Cohen, Steers investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Cohen, Steers: Buy or sell? Read more here...

Tags: Cohen, Steers
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Next Post
PVH Stock

PVH Shares Display Technical Resilience Following Minor Pullback

Apellis Stock

Insider Tax Sale Weighs on Apellis Shares as Analysts Maintain Bullish Outlook

Provident Services Stock

Institutional Investment Fuels Provident Financial Services Shares

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com